ONTARIO, Calif.--(BUSINESS WIRE)--The Prime Healthcare Foundation and the Central Maine Healthcare (CMH) Board of Directors announced they have reached an agreement for Prime Healthcare Foundation to ...

Prime Medicine secures up to $24 million from the CF Foundation to advance Prime Editors for cystic fibrosis treatment. Prime Medicine, Inc. has announced an agreement with the Cystic Fibrosis ...

On Wednesday, December 19, 2024, Foundation announced the release of its newest device, the Passport Prime. Introducing Passport Prime – Your Personal Security Platform! We’re thrilled to present ...

BETHESDA, Md.--(BUSINESS WIRE)--Today, the Cystic Fibrosis Foundation announced that it will provide up to $15 million to Prime Medicine for preclinical research into gene editing for cystic fibrosis.

-- Multiple hotspot Prime Editors may benefit more than 93% of people with CF -- CAMBRIDGE, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (PRME), a biotechnology company committed to ...

In late November, Ontario, Calif.-based Prime Healthcare’s nonprofit public charity, Prime Healthcare Foundation, received state approval to acquire Lewiston-based Central Maine Healthcare. The ...